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consciously aware of how they evaluate a plan or how they 
perform complex clinical judgments. In an approach similar 
to what has been done in radiology, we studied the feasibility 
of using eye-tracking techniques to enhance the 
understanding of how decision makers interact with the given 
visual information during treatment plan evaluation. We 
aimed to verify if eye-fixation positions would be indicative 
of the clinical radiation plan evaluation process.  
Materials and Methods: Single slice dose distributions of 10 
prostate cancer treatment plans were presented to 8 decision 
makers. Their eye-fixation positions were recorded with an 
EyeLink1000 remote eye-tracker. The position was 
determined through pupil and corneal reflection created by 
infrared illumination, with an average accuracy of 0.5°, 
corresponding to 6mm spatial accuracy for our set-up. Total 
evaluation time, dwell time, number and duration of 
fixations on pre-segmented areas of interest involving the 
main structures were measured.  
Results: The median value of time spent by decision makers 
looking at the PTV was 39% (min=3%; max=86%), at the 
rectum 5% (min=0%; max=37%) and at the bladder 17% 
(min=0; max=74%). The remaining time was spent looking at 
femoral heads, isodose lines and information legend 
(structure and isodose colors and values). The relatively long 
time spent on the bladder is probably due to its large volume 
and its central position in the slice, making it the most 
prominent feature. The main structures receiving longer 
fixations (PTV, rectum, bladder) correspond to the main 
trade-offs evaluated in a typical prostate plan. Our results 
show variability among decision makers, indicating that they 
have different behaviors when looking at the plans. 
 
 
 
Typical treatment plan evaluated by a decision maker. Eye-
fixations are the blue circles. The circle diameters represent 
the fixation duration. 
Conclusions: Our study is the first to show the feasibility of 
using the eye-tracking method during radiotherapy treatment 
plan evaluation. The correspondence between where the 
decision makers are looking and how it influences the 
decision process still has to be investigated in details, but our 
results suggest that eye-tracking can be used to explore how 
they visually interact with the given information in order to 
perform clinical judgments.  
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Purpose/Objective: Variability in radiation sensitivity 
between patients has been shown to have a genetic 
component. This genetic component may play an important 
role in explaining the fluctuating rates of radiation-induced 
toxicities (RITs) reported in the literature. However, single 
nucleotide polymorphisms (SNPs) have yielded inconsistent 
results in delineating RITs. Copy number variations (CNVs) 
have been implicated in inflammatory diseases but not yet 
investigated in RITs. Furthermore, clinical and dosimetric 
factors may present confounding effects. Therefore, we are 
evaluating and comparing NTCP data-driven and analytical 
radiogenomic modelling approaches to investigate the 
association of CNVs and SNPs alongside clinical and 
dosimetric variables in late radiation induced rectal bleeding 
(RB) and erectile dysfunction (ED) for prostate cancer 
patients.  
Materials and Methods: A cohort of 100 prostate cancer 
patients who underwent hypofractionated radiotherapy (66 
Gy in 22 fractions) between 2001-2010 was retrospectively 
genotyped for SNPs and sequenced for CNVs. Candidate genes 
were selected based on SNPs previously reported to be 
associated with prostate RITs. Genetic variables consisted of 
SNPs and CNVs of three DNA repair genes (xrcc1, xrcc1, 
ercc2), two growth factors (tgfβ1, vegf) and a radical 
scavenger gene (sod2). Radiogenomic modelling was 
performed using multi-metric data-driven and analytical 
frameworks which were based, respectively, on logistic 
regression data-mining and on the generalized LKB model. 
Performance was evaluated using receiver operating 
characteristic area under the curve (AUC) and statistical 
resampling by cross-validation.  
Results: No clinical variables improved the fit of the models. 
Inclusion of biological variables into the modelling 
frameworks improved the fit of ED and RB analytical and 
data-driven models (Figure 1A,1B). Cross-validated analytical 
model classification performance (AUC) was improved by 
10.2% and 4.8% for RB and ED, respectively, when genetic 
variables were included. Similarly, data-driven models 
increased in AUC by 22.7% and 6.8% for RB and ED, 
respectively (Table 1). 
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Table 1. Comparison of cross-validated ROC AUCs for both 
endpoints. 
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Purpose/Objective: In this prospective study we investigated 
which anatomical structures that are related to trismus after 
radiation therapy in head and neck cancer (HNC). 
Materials and Methods: 216 consecutively included patients 
with HNC were prospectively followed regarding trismus both 
with respect to mouth opening measured in millimeters (MIO-
Maximal Interincisal Opening) and with validated patient-
reported outcome instruments (European Organization for 
Research and Treatment of Cancer Head and Neck 
Questionnaire (EORTC QLQ-HN35) and Gothenburg Trismus 
Questionnaire (GTQ)). Trismus was defined as any event 
during the first year of follow-up. Patients were assessed 
before radiotherapy and at 3, 6, and 12 months after 
completed oncological treatment. Mean absorbed doses of 
seven potential risk structures (masseter muscle, lateral and 
medial pterygoid muscle, temporal muscle, 
temporomandibular joint, soft palate, and, pterygopalatine 
ganglion (ipsi-, contra-, and bilateral)) were used in logistic 
regression analyses to create predictive models for radiation-
induced trismus.  
 
Results: For all three endpoints (MIO, GTQ, and, EORTC QLQ-
HN35,) we found that mean doses to the masseter muscle and 
the temporomandibular joint were statistically significant 
predictors for trismus. Results for ipsi-, and bilateral 
structures were comparable and the predictive ability given 
by the contralateral risk structures was lower in general. 
Smoking and height were significant risk factors for trismus 
according to MIO, and comorbidity (ACE-27) for trismus 
according to GTQ. Dose to the ipsilateral masseter as 
predictor for trismus according to GTQ, adjusted for ACE-27, 
provided the model with the overall strongest predictive 
ability (Az =0.78).  
Conclusions: Among seven risk structures, masseter muscle 
dose gives the strongest prediction of trismus. The masseter 
muscle may therefore be a possible candidate for future 
organ-sparing techniques to avoid trismus in cases where the 
masseter muscle dose can be safely lowered without 
jeopardizing tumor control. 
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Purpose/Objective: By collecting information from 
electronic health records of large numbers of patients, we 
have entered the era of rapid learning health care (RLHC). 
RLHC systems provide us with an ever-growing amount of 
data and pose the challenge to analyze these data in a 
meaningful way. One area to which RLHC is being applied is 
that of predicting acute dysphagia in non-small cell lung 
cancer (NSCLC) patients. 
Acute dysphagia occurs frequently during concurrent chemo-
radiation or high-dose radiotherapy for lung cancer. It is a 
dose limiting toxicity that can lead to treatment 
interruptions and thereby reduce chances of survival. 
Previously, we have developed models to predict this 
toxicity. However, the performance of these models is not 
perfect. This may be because these models were based on 
data from historical patients (e.g. 3D-CRT) which do not 
reflect current practice (e.g. IMRT and VMAT). In this study, 
we investigated whether a model, that attributes more 
weight to recent patient data in its training set, predicts 
dysphagia with a higher accuracy than a model that treats old 
and new data as equally important. 
Rectal Bleeding (RB)  Analytical Data-driven 
Radiogenomic 0.547 0.794 
Dosimetric 0.522 0.747 
Erectile Dysfunction (ED) Analytical Data-driven 
Radiogenomic 0.618 0.707 
Dosimetric 0.562 0.577 
